Degrader target protein α-synuclein（Arvinas）

N/A

Report date: 2023/03/02 17:26:16
NME

Base Information

Drug NameDegrader target protein α-synuclein（Arvinas）
Drug Alias NameAlpha Synuclein PROTACs（Arvinas）Alpha-synuclein targeted therapeutics（Arvinas）
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionSynuclein alpha degraders
TargetsSynuclein alpha
Therapy Area/IndicationsParkinson DiseaseMultiple System Atrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArvinas Inc
China Registration ClassN/A

Develop Information

Active CompaniesArvinas Inc
Inactive CompaniesN/A
Active IndicationsParkinson DiseaseMultiple System Atrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A